IMR Press / FBL / Volume 15 / Issue 1 / DOI: 10.2741/3621

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Article
Immunoregulatory cells of the tumor microenvironment
Show Less
1 Tom Baker Cancer Centre, Division of Surgical Oncology, Calgary, Alberta, Canada
Front. Biosci. (Landmark Ed) 2010, 15(1), 291–308; https://doi.org/10.2741/3621
Published: 1 January 2010
Abstract

Current immune therapies for cancer have been disappointing. The various approaches to immunotherapy for cancer so far tried clinically include adoptive immunotherapy, vaccination strategies, and administration of anti-tolerogenic antibodies. Each of these approaches basically involves the inhibition or circumvention of immune tolerance, activating immune effectors that have the capability to recognize and lyse tumor. Unfortunately, only a relatively small population of patients respond to these therapies, and most of the responses are not durable. There is mounting evidence that immune interventions employing anti-tolerogenic strategies are insufficient to control tumor, as the tumor microenvironment is generally immunosuppressive. The present review summarizes the current knowledge on the cellular constituents of tumor (excluding tumor cells themselves) that contribute to this immunosuppressive microenvironment.

Share
Back to top